Markets
China IPOs chart
Sherwood News

Chinese IPOs in the US have been making a comeback... of sorts

Even with ~$6 billion tea giant Chagee now in the mix, the current landscape still seems to be deterring bigger names.

4/23/25 9:38AM

Strange as the timing may seem, given the broader geopolitical picture, many Chinese companies are seeing 2025 as the year to hit the US public market. Last week, tea giant Chagee soared 21% on its Nasdaq debut to hit a $6.2 billion valuation, while a flurry of tech firms are reportedly looking to follow suit, per Bloomberg.

Red wave

Chagee’s $411 million raise last Thursday made it the largest Chinese consumer company listing in the US since 2021, momentarily bucking the drought of big Chinese initial public offerings that had been attributed to deteriorating relations between the two nations. Still, even against the backdrop of President Trump’s ongoing tariffs, postponed IPOs from other companies, and talk of Chinese stocks being delisted from US exchanges, 2025 has largely picked up where last year left off in terms of enticing companies looking to list in the US.

China IPOs chart
Sherwood News

There was once a time when Chinese tech companies deciding to go public in America would shake Wall Street, like e-commerce behemoth Alibaba’s IPO in 2014, which initially raised $21.8 billion and was later valued at $25 billion, making it the largest in history at the time. While a host of companies followed suit, the surge wasn’t to last: after Chinese ride-hailing company DiDi Global decided to go public on the NYSE in 2021 — despite not getting the green light from Beijing regulators — it was forced to delist by the Chinese government, complicating the listing process ever since

The tide has been slowly shifting recently, with Chinese offerings on the US market up almost 47% in 2024 compared to the year before, per data from US-China Economic and Security Review Commission (USCC). However, the precarious regulatory landscape was clearly a hurdle that many bigger companies were wary of even before the latest tariffs, with the 37 offerings in 2024 worth just $1.9 billion, down from $10.7 billion just four years earlier.

Interestingly, there had already been 11 offerings from companies based in Shanghai, Beijing, and beyond by March 7 this year, according to the USCC, as China’s government continues to boost and protect its domestic businesses.

More Markets

See all Markets
markets

SpaceX spectrum deal sends would-be rivals lower

Shares of struggling satellite services company EchoStar soared Monday, after the company — which had recently tottered close to bankruptcy — announced the sale of some of its wireless spectrum licenses to Tesla CEO Elon Musk’s SpaceX for $17 million.

The sale provides a competitive advantage to Musk’s growing Starlink satellite services business, as the licenses it is acquiring from Echostar allows Starlink to operate ground based broadband and cellphone services, the Wall Street Journal reported.

Entities that stood to be hurt by the emergence of a Musk-led SpaceX Starlink service got hit hard on the news. AST SpaceMobile, which has plans to offer a similar satellite-to-consumer cellular service, tumbled.

So did wireless tower providers like Crown Castle and American Tower. Low cost cellular service provider T-Mobile, which had a deal with SpaceX, also slumped, as Luke noted earlier, along with other large wireless telecommunication services providers.

The wireless telecommunications industry grouping within the S&P 500 was down more than 2.5% shortly after noon, making it the worst performing industry within the S&P 500 on Monday.

Entities that stood to be hurt by the emergence of a Musk-led SpaceX Starlink service got hit hard on the news. AST SpaceMobile, which has plans to offer a similar satellite-to-consumer cellular service, tumbled.

So did wireless tower providers like Crown Castle and American Tower. Low cost cellular service provider T-Mobile, which had a deal with SpaceX, also slumped, as Luke noted earlier, along with other large wireless telecommunication services providers.

The wireless telecommunications industry grouping within the S&P 500 was down more than 2.5% shortly after noon, making it the worst performing industry within the S&P 500 on Monday.

markets

Hims rises, Novo dips after FDA releases “green list” of GLP-1 raw material suppliers

Hims & Hers rose and Novo Nordisk slipped in early trading after the US Food and Drug Administration released a "green list" of foreign GLP-1 ingredient suppliers that it considers in compliance with agency standards.

Some telehealth companies like Hims sell copycat versions of Novo's and Eli Lilly’s blockbuster weight-loss drugs through compounding pharmacies, which take the active ingredients from FDA-approved medications and make adjusted, or "personalized,” versions of the drug for patients.

Novo and Lilly have fought against this, arguing that it infringes on their intellectual property. They've sued smaller telehealth providers, pharmacies, and clinics in lieu of any action against them from the FDA. Instead, the FDA gave compounders a list of suppliers it deems safe.

Recent developments in the cases filed by the drugmakers so far as well as the FDA's recent actions suggest telehealth companies may be in a less risky position than investors previously thought. As of Monday morning, prediction markets pegged the likelihood of a suit from Novo against Hims at 34%, down from about 70% earlier this month.

markets

UNH rises after saying it plans to reiterate outlook

UnitedHealth rose 2% in early trading after it disclosed that it plans to reiterate its full-year earnings outlook when it meets with investors this week.

The company said on July 29 that it was expects to report annual adjusted earnings per share of at least $16. The company had previously pulled full-year guidance and prior to that withdrawal, had told investors it expected to see earnings of $26 to $26.50 per share.

Currently, a analysts polled by FactSet are penciling in $16.23, compared to $17.21 before the guidance came down.

UnitedHealth has had a tumultuous year as he industry has been hit with rising costs of care, and UnitedHealth specifically has been hit with investigations into its Medicare Advantage practices. It recently got a boost after Warren Buffett's Berkshire Hathaway revealed that it's built a stake in the company

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.